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Abstract: (1) Background: Several factors have been suggested to be associated with the
physiopathology of frailty in older adults, and nutrition (especially protein intake) has been attributed
fundamental importance in this context. The objective of this study was to conduct a systematic
review and meta-analysis to investigate the relationship between protein intake and frailty status
in older adults. (2) Methods: A search of scientific studies was conducted in the main databases
(Medline, Scopus, Cochrane library), and in the reference lists of selected articles. The search terms
included synonyms and Medical Subject Headings and involved the use of Boolean operators which
allowed the combination of words and search terms. Observational studies—cross-sectional and
longitudinal—that met the eligibility criteria were included in the review. Article selection and data
extraction were performed by two independent reviewers. Meta-analyses with random effects were
performed. Publication bias was measured using the Strengthening the Reporting of Observational
Studies in Epidemiology instrument. (3) Results: In the final sample, 10 articles, seven cross-sectional
and three longitudinal, were included in the present study. Overall, studies investigated a total
of 50,284 older adults from three different continents between 2006 and 2018. Four cross-sectional
studies were included in the meta-analyses. The results demonstrated that a high protein intake was
negatively associated with frailty status in older adults (odds ratio: 0.67, confidence interval = 0.56 to
0.82, p = 0.0001). (4) Conclusions: Our findings suggest that a high consumption of dietary protein is
inversely associated with frailty in older adults.
Keywords: frailty; protein intake; older adults
1. Introduction
The aging process is a continuous phenomenon characterized by alterations in major physiological
systems, accompanied by the development of chronic diseases and geriatric syndromes, such as frailty.
Frailty may be conceptualized as a multidimensional geriatric clinical state that involves multiple signs
and symptoms leading to extreme vulnerability to stressors and resulting in increased risk of negative
health-related outcomes (e.g., functional decline, disability, falls, hospitalization, institutionalization,
death) [1,2].
Nutrition is acknowledged as a major factor in the context of frailty. In fact, malnutrition is
considered one of the pillars for the development of this condition [3], since it can influence all
diagnostic criteria for frailty (i.e., unintentional weight loss, low muscle strength, exhaustion, reduced
physical activity levels, and slow walking speed) [4]. Three previous systematic reviews have been
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conducted on the association between nutrition and frailty. Authors observed that several factors
might be responsible for this close relationship between frail and nutrition, including oral health,
nutritional status, dietary patterns, diet quality, the antioxidant capacity of the diet, micronutrients
and macronutrients intake [3,5]. Nevertheless, protein intake might be the main factor behind this
relationship, through its actions on muscle mass and strength.
Indeed, human skeletal muscle protein turnover comprises the process of muscle protein synthesis
and muscle protein breakdown [6–8]. On one hand, muscle hypertrophy occurs when the rates
of protein synthesis exceed protein breakdown, which may be elicited by hyper amino acidemia
induced by dietary protein intake; on the other hand, an inadequate protein intake leads to lower
protein synthesis rate, resulting in net protein breakdown and muscle catabolism [6–8]. During aging,
numerous process collaborate to a reduced protein intake, such as lack of hunger, impaired oral
health, and loss of acuity in taste, smell and sight, to quote a few [9]; consequently, collaborating
to muscle catabolism [9]. In addition, evidence has demonstrated that the anabolic response to
hyper aminoacidemia may be blunted in older adults [10,11], which indicate that this population
should consume larger amounts of protein in comparison to young adults in an attempt to maintain
muscle protein synthesis. Nevertheless, over time, the lack of adequate protein intake leads to a
state called as sarcopenia [9,12,13], which is characterized by marked muscle atrophy, dynapenia,
and reduced physical function, all variables encompassed on frailty definition [14]. If there is no
immediate intervention to reduce sarcopenia and frailty progression, as well as improve protein intake,
the patients will develop a severe physical disability and consequently exhaustion and sedentary
behavior [1,15].
It should be stressed that other pathways besides sarcopenia may be also responsible for the
association between protein intake and frailty, since evidence has demonstrated that protein intake is
associated with dementia, global cognitive scores, visuospatial skill, nonverbal memory, and logical
memory in older adults [16–18]; all aspects linked with frailty [1].
However, investigations on the association between protein intake and frailty have shown positive,
negative and even null results. In addition, to the best of our knowledge, there is a lack of systematic
reviews and meta-analysis dedicated to investigating the relationship between protein intake and
frailty in older adults.
Therefore, the present study was conducted to perform a systematic review to identify and
compare studies reporting the relationship between frailty status and protein intake in older adults.
Additionally, data were combined to calculate the pooled overall relationship between frailty status
and protein intake.
2. Materials and Methods
We conducted a systematic review and meta-analysis of observational studies to investigate
and quantify the association between protein intake and frailty in older adults. The study was fully
performed by investigators and no librarian was part of the team. This study complies with the criteria
of the Primary Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) Statement [19]
and the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines [20].
2.1. Eligibility Criteria
The inclusion criteria of the present study consisted of: (a) observational studies, including
cross-sectional, case-control and longitudinal studies, which investigated as primary or secondary
outcome the association of protein intake and frailty in older adults; (b) study sample 60 years or older;
(c) frailty defined by a validated scale; (d) reported information on the proportion of frailty among
those with high and low levels of protein intake; (e) published studies (English language). To be
included in the meta-analysis, in addition to the aforementioned inclusion criteria, the investigations
had to provide: (f) at least two groups divided according to protein intake (e.g., high and low),
(g) the prevalence of frailty in each group, (h) and the total sample size in each group. We excluded
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randomized-clinical trials (RCTs), quasi-experimental, cross-over studies and any kind of investigation
which examined the effects of a nutritional intervention associated or not with other interventions
(e.g., physical exercise) on frailty. Studies that classified the volunteers as frail according to reduced
physical/or cognitive function were also excluded.
2.2. Search Strategy and Selection Criteria
Studies published on or before July 2018 were retrieved from the following three electronic
databases by one investigator: (1) PubMed, (2) the Cochrane Library, and (3) SCOPUS. Reference lists
for reviews and retrieved articles for additional studies were checked and citation searches on key
articles were performed on Google Scholar and ResearchGate for additional reports. Initially, a search
strategy was designed using keywords, MeSH terms, and free text words such as protein intake, frailty,
older adults. Additionally, keywords and subject headings were exhaustively combined using Boolean
operators. The complete search strategy used for the PubMed can be shown in List S1. Only eligible
full texts in English language were considered for review. Authors were contacted if necessary.
2.3. Data Extraction and Quality Assessment
Titles and abstracts of retrieved articles were screened for eligibility by two researchers. If an
abstract did not provide enough information for evaluation, the full-text was retrieved. Disagreements
were solved by a third reviewer. Reviewers were not blinded to authors, institutions, or manuscript
journals. Data extraction was independently performed by two reviews using a standardized coding
form. Disagreements were solved by a third reviewer. Coded variables included methodological
quality and the characteristics of the studies. The quality of reporting for each study was performed
by two researchers using the Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) instrument [21]. The agreement rate between reviewers was κ = 0.98 for quality assessment.
2.4. Statistical Analysis
The meta-analysis was conducted using Revman V.5. Effect sizes (ESs) were measured using odds
ratio (OR) and 95% confidence intervals (CIs). The OR indicates the risk for frailty according to protein
intake, high in relation to low. A significant OR is required to have a 95% confidence interval (CI 95%)
that did not include the value of 1 and a p value for the test of significance of the total overall effect (Z)
lower than 0.05. An inverse variance random-effect model was used to calculate the pooled ES since
the studies demonstrated different characteristics regarding the main aspects associated with frailty
(e.g., modified frailty criteria), protein intake (e.g., different cut-offs for high and low protein intake
definition), and covariates (e.g., energy intake). Funnel plots and Egger’s regression analysis were
used to evaluate the publication bias. Heterogeneity across studies was tested using the Q-statistics
and I2 index was used to assess inconsistency [22]. Additionally, I2 index was classified as might not
be important (0–40%), may represent moderate heterogeneity (30–60%), may represent substantial
heterogeneity (50–90%), and considerable heterogeneity (75–100%) [22]. Forest plots were used to
illustrate summary statistics and the variation (heterogeneity) across studies.
3. Results
3.1. Literature Search
Of the 2555 registers recovered from electronic databases and hand search, 2523 records were
excluded based on duplicate data, title or abstract. Thirty-two studies were fully reviewed and assessed
for eligibility. Finally, 10 studies met the inclusion criteria (Figure 1).
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3.2. Characteristics of the Included Studies
Table 1 provides a general description of the included studies. Overall, a total of
18,120 community-dwelling older adults from five different countries (France, Germany, Italy, Japan,
and the United States of America) were investigated between 2006 and 2018 in the cross-sectional
studies. Frailty a sessment wa performed with two tool . The frailty phenotype proposed by
Fried et al. (2001) was used i six of the seven studies [23–28], while one stu y used the Kihon
checklist (KCL) [29]. However, it is important to mention that the frailty phenotype [14] was modified
in 5 of the 6 studies. Indeed, weight loss criterion was modified in the studies of Rahi et al. [28]
and Shikany et al. [27], while Bartali et al. [23] removed this variable. In turn, in the investigations
performed by Kobayashi et al. [24,25], slowness and weakness were indirectly measured based on a
questionnaire. Slowness assessment was also modified in the study of Rahi et al. [28] Dietary intake
was primarily assessed by population-specific food-frequency questionnaires (FFQ) (57.1%) [23,26,27],
followed by self-administered diet history questionnaires (28.6%) [24,25], and the 24 h dietary recall
(14.3%) [28]. High and low protein intake was differently defined in the investigations. Measures of
centrality (e.g., tertiles, quartiles, quintiles) were used in 6 of the 7 studies [23–27], while Rahi et al. [28]
performed the analysis based on a pre-established cut-off (i.e., protein intake l vels ≥ 1 g/kg of body
weight). Regar ing longitudinal studies, 32,164 community- welling older ad lts were investigated
between 2010 and 2016. The studies were conducted in North America (United States of America) and
Europe (Spain). The mean duration of follow-up was 3.7 years (3.0–4.6 years). The frailty phenotype
was used in all studies for frailty assessment. However, as was observed in cross-sectional studies,
the frailty phenotype was odified in 2 of the 3 longitudinal studies. Shikany et al. [27] considered
the loss of appendicular lean mass as a measur ment f weight loss. In turn, Beasley et al. [30] used
a modified version of frailty phenotype as they measured muscle weakness and slowness using the
Rand-36 Physical function scale. FFQ (66.6%) and computerized face-to-face diet history (33.3%) were
used for a dietary intake assessment. In longitudinal studies, all investigations used measures of
centrality (i.e., quartile and quintile) to determine the levels of protein intake.
Nutrients 2018, 10, 1334 5 of 14
Table 1. General description of the included studies.
Year Authors Country StudyDesign Setting n
Mean Age
(age range;
min–max)
Sex Ratio of
Participants
(female/male)
by frail vs.
non-frail
Frailty
Assessment
Method
Dietary Intake
Assessment
Method
Protein
Intake
(g/day)
Protein Intake
Level Definition Outcomes Covariates Included in Models
Quality
Analysis
Score
Cross-sectional
2006 Bartaliet al. [23] Italy
Cross-
sectional
Community-
dwelling 802 74.1 1.2
CHS frailty
index (a)
Food-frequency
questionnaire - Dichotomous
Low protein
intake is
associated
with frailty
Results were adjusted for age,
sex, education, economic status,
household composition,
smoking status, number of
diseases, cognitive function,
body mass index,
and “happiness.”
22
2013 Kobayashiet al. [24] Japan
Cross-
sectional
Community-
dwelling 2108 74.7 -
CHS frailty
index (b)
Self-administered
diet history
questionnaire
74.0
Quintile
(≤62.9 g/day,
6369.8 g/day,
69.8–76.1 g/day,
76.1–84.3 g/day,
≥84.3 g/day)
Protein intake
was inversely
associated
with frailty
Results were energy-adjusted
and for age, BMI, residential
block, size of residential area,
living alone, current smoking,
alcohol drinking, dietary
supplement use, history of
chronic disease, depression
symptoms, and energy intake.
20
2013 Bollweinet al. [26] Germany
Cross-
sectional
Community-
dwelling 194 83.0 (75–96) 6.5 vs. 1.3
CHS frailty
index
Food-frequency
questionnaire 76.6
Quartiles
(≤0.90,
0.91–1.07, 1.08,
≥1.27)
Protein intake
was not
associated
with frailty
Results were adjusted for age
and sex, instrumental activities
of the daily living score, number
of medications,
and chewing difficulties
19
2014 Shikanyet al. [27]
United States
of America
Cross-
sectional
Commnity-
dwelling 5925 75.0 -
CHS frailty
index (c)
Food-frequency
questionnaire -
Quintile
(≤6.0–13.7%,
13.8–15.2%,
15.3–16.5%,
16.6%–18.3%,
18.4–29.3%)
Protein intake
was not
associated
with frailty
Results were adjusted for age,
race, center, education, marital
status, smoking, health status,
medical conditions, body mass
index, and energy intake
20
2016 Rahiet al. [28] France
Cross-
sectional
Community-
dwelling 1345 75.6 4.0 vs. 1.46
CHS frailty
index (d)
24 h dietary
recall 70.4
Dicothomous
<1g/kg body
weight/day
and ≥1g/kg
body weight
Protein intake
was associated
with frailty
The model 1 was adjusted for
age, sex, and educational level;
and the model 2 was
additionally adjusted for BMI,
diabetes, cardiovascular history,
depression, cognitive
performance, number of drugs,
and total energy intake.
20
2017 Kobayashiet al. [25] Japan
Cross-
sectional
Community-
dwelling 2108 74.0 -
CHS frailty
index (b)
Self-administered
diet history
questionnaire
73.1
Tertile
(≤67.6 g/day,
67.6–78.3 g/day,
≥78.3 g/day)
Protein intake
was inversely
associated
with frailty
Dietary total
antioxidant capacity 20
2018 Nanriet al. [29] Japan
Cross-
sectional
Community-
dwelling 5638 73.2 0.88 vs. 1.05 * KCL
Food-frequency
questionnaire -
Men = quartiles
(≤48.8 g/day,
48.8–56.1 g/day,
56.1–65.4 g/day,
>65.4 g/day);
Women =
quartiles
(<43.8 g/day,
43.8–51.1 g/day,
51.1–59.5 g/day,
>59.5 g/day)
Protein intake
was inversely
associated
with frailty
For men, the model 1 was
adjusted forage, body mass
index, total energy intake,
alcohol status, smoking status
and history of disease and the
model 2 was adjusted for family
structure, educational
attainment, population density,
and self-related health.
20
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Table 1. Cont.
Year Authors Country StudyDesign Setting n
Mean Age
(age range;
min–max)
Sex Ratio of
Participants
(female/male)
by frail vs.
non-frail
Frailty
Assessment
Method
Dietary Intake
Assessment
Method
Protein
Intake
(g/day)
Protein Intake
Level Definition Outcomes Covariates Included in Models
Quality
Analysis
Score
Longitudinal
2010 Beasleyet al. [30]
United States
of America
Longitudinal
(3.0 years
follow-up)
Community-
dwelling 24,417 65–79 -
CHS frailty
index (e)
Food-frequency
questionnaire 72.8
Quintiles of
protein intake
(% kilocalories)
Protein intake
was
significantly
associated with
the odds of
becoming frail
Results were adjusted for age,
ethnicity, BMI, income,
education, having a current
health care provider, smoking,
alcohol, general health status,
history of comorbid conditions,
history of hormone therapy use,
number of falls, whether
participant lives alone, disabled
defined by at least 1 activity of
daily living affected, depressive
symptoms, log-transformed
calibrated energy intake
20
2014 Shikanyet al. [27]
United States
of America
Longitudinal
(4.6 years
follow-up)
Community-
dwelling 5925 75.0 -
CHS frailty
index (c)
Food-frequency
questionnaire -
Quintile
(≤6.0–13.7%,
13.8–15.2%,
15.3–16.5%,
16.6%–18.3%,
18.4–29.3%)
Protein intake
was not
associated with
the odds of
becoming frail
Results were adjusted for age,
race, center, education, marital
status, smoking, health status,
medical conditions, body mass
index, and energy intake
20
2016 Sandoval-Insaustiet al. [31] Spain
Longitudinal
(3.5 years
follow-up)
Community-
dwelling 1822 68.7 0.9 vs. 2.4
CHS frailty
index
Computerized
face-to-face diet
history
76.6 Quartiles ofprotein intake
Protein intake
was associated
with the odds of
becoming frail
Results were adjusted for age,
energy intake, ethanol, lipids,
animal or vegetal protein, level
of education, marital status,
tobacco consumption, BMI,
abdominal obesity,
and dietary fiber, diseases.
20
CHS = Cardiovascular Health Study; KCL = Kihon checklist; bw/d = body weight/day; BMI= Body mass index; (a) Bartali et al. used a modified version of the CHS frailty index, since
weight loss was removed; (b) Kobayashi et al. used the CHS frailty index version modified by Woods et al as they did not have direct measures of gait speed and strength; (c) Shikany et al.,
used a modified version of the CHS frailty index as they measured weight loss criterion based on loss of appendicular lean mass; (d) Rahi et al., used a modified version of the CHS frailty
index as a loss of 3 kg and a reduced BMI (<21 kg/m2) were both accepted as measures of weight loss criterion, slowness was determined based on the Rosow-Breslau test, and weakness
was identified using the chair standing method (e) Beasley et al., used a modified version of the CHS frailty index as they measured muscle weakness and slow walking speed using the
Rand-36 Physical function scale; * frail vs non-frail.
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3.3. Quality Assessment
The overall score of the quality assessment of cross-sectional and longitudinal studies is shown
in Table 1 and the analysis of each variable is detailed in Tables S1 and S2, respectively. The point
by point analysis is shown in Table S3. The overall score of cross-sectional studies ranged from 19 to
22. All studies reported the items required by the STROBE criteria in relation to the abstract (items
1 and 2), objectives and hypothesis (items 3 and 4), described the settings, locations, relevant dates,
eligibility criteria and the source and methods of selection of participants (items 5 and 6), clarity of
the outcomes (items 7), methods of assessment (item 8), handle of the quantitative variables (item
11), give the characteristics of study participants (item 14), reported the number of outcome events
(item 15), statistical methods and analysis (items 12, 16, 17), and discussion (items 18–21).However,
57.1% of the studies failed to clearly report the efforts performed to address potential sources of bias
(item 9) [24,26–28], 42.9% did not properly explain how the study size arrived at (item 10) [26–28],
and 14.3% did not show the number of individuals at each stage of study (item 13) [26].
Similar results were seen in longitudinal studies, in which all investigations received a STROBE
score of 20. None of the studies adequately presented a description of how the study was arrived at
(item 10), while 66.6% failed to describe any efforts to address potential sources of bias (item 9) [27,31],
and 33.3% did not show the number of individuals at each stage of study (item 13) [30].
3.4. Association between Protein Intake and Frailty
3.4.1. Protein Intake and Frailty Prevalence (i.e., Cross-Sectional Studies)
A total of four studies provided information regarding different intakes of protein in at least two
groups, the prevalence of frailty in each group, and the total sample size in each group; therefore,
they were added in the meta-analysis (Figure 2). Two aspects should be mentioned before the
presentation of data. First of all, Nanri et al. [29] provided the data according to gender, and the
results are presented accordingly. In turn, the investigations performed by Kobayashi et al. [24,
25] used the same database (i.e., Three-generation Study of Women on Diets and Health), so that
the studies were not analyzed in combination. The overall meta-analysis results showed a 0.67
OR (Figure 2a) and a 0.66 OR (Figure 2b) for frailty (95% CI = 0.56 to 0.82, p = 0.0001; 95% CI =
0.54 to 0.80, p = 0.0001) in older adults with high protein intake compared with low protein intake
according to the inclusion of Kobayashi et al. [24] or Kobayashi et al. [25], respectively. When the
study of Kobayashi et al. [25] was not in the analysis, it was possible to observe an I2 lower than 40%
accompanied by a p = 0.18, indicating that this heterogeneity might not be important [22]. However,
when the study of Kobayashi et al. [24] was removed, the I2 increased to 49% and p value was of 0.12,
which can indicate a moderate heterogeneity [22].
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Figure 2. Odds ratio (OR) of the prevalence of frailty in older adults with high and low protein intake.
Squares represent study-specific estimates; diamonds represent pooled estimates of random-effects
meta-analyses. (a) The analysis was performed included Kobayashi et al. 2013; (b) The analysis was
performed included Kobayashi et al. 2017.
Figure 3 shows the funnel plots (a) and (b) based on the primary outcome according to
the inclusion of Kobayashi et al. [24] or Kobayashi et al. [25], respectively. The figures are
asymmetrical indicating that potential publication bias might influence the results of this review.
Egger’s linear regression test indicated possible publication bias for the association when the study of
Kobayashi et al. [24] was included (p = 0.02), but not Kobayashi et al. [25] (p = 0.09).
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e found three studies that evaluated the longitudinal relationship bet een protein intake and
frailty risk. The findings de onstrate that t o of the three studies observed that higher protein intake
was negatively associated with frailty risk.
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4. Discussion
Frailty is a multifactorial condition associated with poor prognosis. Low protein intake has been
proposed among the factors possibly involved in the pathogenesis of frailty. We, therefore, performed
a systematic review and meta-analysis to investigate the relationship between protein intake and frailty
in older adults. The main findings of the present study indicate that low protein intake is associated
with frailty prevalence in older adults.
Study quality assessment demonstrated that reports were of very good quality, such that
cross-sectional studies scored between 19 and 22 and all longitudinal studies scored 20. Interestingly,
cross-sectional and longitudinal studies did not provide the same items, including efforts to address
potential sources of bias (item 9), the design of the study size (item 10), and the report regarding the
number of participants in all the phases of the study (item 13).
Some recent systematic and descriptive reviews have investigated the relationship between
nutrition and frailty [3,4,32,33]. However, none of these studies was specifically designed to investigate
the role of protein intake in this phenomenon and the findings were not quantitatively assessed.
Thus, to the best of our knowledge, this is the first systematic review and meta-analysis designed to
investigate the relationship between protein intake and frailty in older adults.
The results of the present study may be at least partially explained by the theoretical overlap
between sarcopenia and physical frailty [34,35]. Indeed, physical frailty, as measured by the
Fried’s criteria [14,36], encompasses features as slowness, weakness, exhaustion, and sedentary
behavior, which are strongly associated with the sarcopenia condition [34,35]. Slowness
(i.e., slow walking speed) and weakness (i.e., low upper-limb muscle strength), for example, are
proposed as diagnostic criteria for sarcopenia by the European Working Group on Sarcopenia in
Older Persons (EWGSOP) [15], while exhaustion and sedentary behavior are common consequences of
sarcopenia progression [37]. Indeed, Landi et al. [35] suggested that sarcopenia may be envisioned as a
central mechanism for the development of physical frailty. In another word, physical frailty may be the
final pathway of sarcopenia progression [35]. This idea is further supported by the higher prevalence
of sarcopenia in pre-frail and frail older adults when compared to non-frail peers [38,39].
Sufficient protein consumption may cause a shifting on net balance in favor of muscle protein
synthesis [7,40]. Protein supplementation per se has been shown to prevent the progression of physical
decline in frail older adults [30,41]. In addition, protein intake has a key role in the physiological
adaptations elicited by the resistance training on the neuromuscular apparatus since a greater muscle
protein synthesis is expected when both non-pharmacological therapies are offered in combination [6,7].
Taken together, these findings suggest that sufficient protein intake may reverse or at least prevent
functional decline in frail older adults.
However, this kind of inference deserves caution since not all evidence has demonstrated the
positive effects of protein supplementation on the sarcopenia aspects associated with frailty, such
as muscle mass, muscle strength and physical function [42,43]. Finally, it should be noted that the
changes observed after protein supplementation may be different from those observed in response to
dietary protein intake.
It is worth mentioning, that our main findings are based on cross-sectional studies and
causal extrapolations should be performed carefully. Unfortunately, there were no available data
from longitudinal studies to perform a meta-analysis. Overall, findings are still controversial.
Shikany et al. [27] observed that protein intake was inversely associated with the risk of transitioning
from robust to pre-frail status in a range of 4.6 years, while there were no significant associations
between protein and frailty status. However, Sandoval-Insausti et al. [31] reported that total protein
and animal protein intake were inversely associated with frailty and its components (i.e., slowness)
over a mean follow-up of 3.5 years. Similarly, Beasley et al. [30] concluded that higher protein intake
was associated with reduced risk of frailty in community-dwelling older women.
Interestingly, the main variables investigated in the present study were differently defined across
the investigations. Regarding frailty, although this variable was assessed using the frailty phenotype
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in most investigations, adaptations of some of the criteria were observed in 5 of the 6 cross-sectional
studies, as well as in 2 of the 3 longitudinal studies. In fact, weight loss criterion was modified in
the trial of Rahi et al. [28], in which researchers included volunteers with self-reported unintentional
loss > 3 kg or as a body mass index < 21 kg/m2, while Shikany et al. [27] included subjects who
lost appendicular muscle mass. In turn, Bartali et al. [23] removed the weight loss criterion of their
investigation. Slowness and weakness were also modified. In this case, Kobayashi et al. [24,25],
Beasley et al. [30], and Rahi et al. [28] (only slowness) used self-reported questionnaires instead of
direct evaluations. It is also possible to observe that different cutoffs to define high a low protein intake
(i.e., tertiles, quartiles, quintiles and pre-established values) were used in the investigations.
These modifications have direct implications in the findings of the present study. Although
scales and questionnaires may offer more information in a shorter period when compared to
performance-based measurements, evidence has demonstrated the limited capacity of these tools
to reflect different measures of physical status [44,45]. This probably occurs because the results
of patient-reported questionnaires may be biased due to mood, motivation, fatigue, health status,
fluctuations in memory, and the specific knowledge and familiarity with the questionnaires and
scales [44,45]. In this sense, different results than those observed in the present study could occur
if the investigations were performance based on direct measures, as proposed by Fried et al. [14].
Furthermore, the use of different cut-offs to define protein intake levels leads to disagreements and
restrict the proposal of public health recommendations to older adults due to the range of approaches
used by the studies.
Taken together, these differences may also explain the heterogeneity of results observed among
the longitudinal studies. Nevertheless, different settings, eligibility criteria, gender, sarcopenia status,
dietary assessment methods, and follow-up periods of the various studies may also explain this
variability. In this sense, more well-controlled cross-sectional and longitudinal studies are still necessary
to improve the actual knowledge about frailty and protein intake in older adults, as well as to confirm
our findings.
We should state the absence of subgroup analyses as the major limitation of the present study.
Indeed, the use of crude OR limits interpretation of our meta-analysis, since the influence of important
covariates (e.g., age, type of protein [animal, vegetal], sarcopenia) were not taken into consideration
in the results, and we recommend that readers interpret our results carefully. The main aspect that
prevented us to perform the analysis was the lack of available data in the included studies. Regarding
dietary assessment, it is worth mentioning that total protein intake, which was used in all studies for
comparisons, is probably not the best parameter to represent adequate protein consumption, since
investigations in the context of physical function and sarcopenia have used relative protein intake
(g/kg/day) [46–48]. In addition, recent evidence has demonstrated that a spread distribution of protein
intake during the main meals is better associated with gait speed than relative protein intake [49].
Providing support to the importance of the distribution of protein intake, Loenneke et al. [50] observed
that a frequent consumption of meals containing at least 30 g of protein was associated with greater
lean mass and lower-limb muscle strength in middle-aged and older adults. The role of animal and
plant-based protein sources on variables associated with frailty has also been the object of discussion
among researchers [51,52]. Therefore, although future investigations are still necessary to confirm our
findings, the present study may serve as a guide for future studies in this field; so that investigation
should include more information regarding the factors that may interfere in the relationship between
protein intake and frailty, taking into account the variables that have been investigated by other studies.
In addition, funnel plots and Egger’s linear regression test indicated that biases from publications
and other factors may have had a significant influence on the results of our meta-analysis mainly
when the study of Kobayashi et al. [24] was included. Possible explanations for this publication bias
included the small number of studies investigated, multiple publication bias, and heterogeneity [22].
Finally, another aspect of the present study that deserves concerns is the use of STROBE instrument
as a tool to quality assessment. As discussed by da Costa et al. [53], STROBE was primarily developed
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to improve the reporting of observational studies. Thus, some may argue that another tool should
have been used in the present study. However, it should be stressed that there is no gold standard tool
to assess the risk of bias in non-randomized studies, as well as some of the STROBE questions may
represent an evaluation of risk of bias; consequently, making it a tool commonly used in systematic
reviews and meta-analysis [53].
In conclusion, our findings support the need for increased protein intake in older adults in an
attempt to avoid frailty development.
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